Abstract-We demonstrate efficient generation of singlet oxygen upon two-photon excitation with 150-fs 780-nm laser pulses of a new porphyrin photosensitizer molecule whose two-photon absorption cross section has been considerably enhanced by chemical design.
section, and demonstrate its ability to generate singlet oxygen upon illumination with near-IR light. Injecting a porphyrin photosensitizer into a patient's blood stream commences a typical PDT procedure. After an appropriate time interval (usually tens of hours), the photosensitizer is activated by shining a visible light, usually a red color laser beam, at the tumor's location [1] , [3] . Photophysical processes constituting PDT are summarized in the energy level diagram shown in Fig. 1 . In its classical implementation, absorption of one visible photon [one-photon excitation (OPE)] brings a photosensitizer molecule into a short-lived excited state with energy of 170-190 kJ mol , which corresponds to an illumination wavelength of 620-690 nm. After a few nanoseconds, the porphyrin undergoes an intersystem crossing to a triplet state with energy of 110-130 kJ mol and with a much longer life time (on the order of milliseconds). From the triplet state, the energy is transferred (semicircle arrows in Fig. 1 ) to omnipresent oxygen molecules by switching them from a triplet ground state into an excited singlet state with excitation energy of 94 kJ mol . Once in the excited singlet state, the oxygen presents an extremely reactive species capable of damaging surrounding tissue in an irreversible manner. A presence of excited singlet oxygen molecules ( ) in solution is usually detected by their luminescence at about 1270 nm (black arrow in Fig. 1 ).
To be effective, the photosensitizers have to selectively accumulate in the tumor tissue. Serendipitously, porphyrin molecules possess this rare feature [3] . The second critical point is how deep can light penetrate into the body without being scattered or absorbed by normal tissue. It is well known that the tissue's transmission depends critically on the illumination wavelength [4] and is the largest in the so-called tissue transparency window at 750-1000 nm. Porphyrins currently in use for PDT fall short of this transparency window: their absorption varies from 620 to 690 nm, where effective penetration in most tissues is no more than just a few millimeters in depth [5] . Unfortunately, attempts to shift the one-photon absorption band toward longer wavelengths by chemical modification of the porphyrin structure come into conflict with the fundamental requirement that the excitation energy of singlet oxygen is lower than the energy of the state. In addition, long-wavelength shift of porphyrin's energy levels often aggravates the situation by reducing compound's stability.
In the view of these mounting difficulties, a proposal to use TPA appears as the best alternative way to achieve PDT. TPA [6] is a third-order nonlinear-optical process and it consists in simultaneous absorption of two photons, so that the illumination wavelength is twice of that of the actual transition wavelength [two-photon excitation (TPE) in Fig. 1 ]. TPA allows using near-IR photons in the tissue transparency window and does not require the red shift of the lowest electronic transition of the porphyrin. Note that even if TPA takes a molecule into one of its' higher excited states , this does not bar the lowest state to be populated via internal conversion. Once this state is formed, the subsequent events follow the same path as described above. In addition, TPA also provides two further advantages: 1) laser-induced hyperthermia is minimized, since near-IR light has a reduced absorption in tissues and 2) nonlinear (quadratic) dependence of TPA on laser intensity provides for higher spatial selectivity of treatment due to the smaller effective size of the focal spot. The latter is essential for treatment of sensitive tissues such as those of age-related wet macular degeneration. On the downside, because the probability of TPA with conventional low-power light sources is vanishing small, laser pulses with high peak intensity are required for the TPA effect to be pronounced. Fortunately, the commercialization of femtosecond mode-locked near-IR Ti : Sapphire lasers has greatly alleviated this last problem.
As one might expect, these useful features have stimulated an active search for new molecular system for TPA-based PDT [7] [8] [9] [10] [11] . Some nonporphyrin-based compounds may indeed possess an impressively large TPA cross section [8] , [9] , [12] . However, they either lack the vital property to generate singlet oxygen or their interaction with biological tissue is not known. On the other hand, all known porphyrin-based sensitizers were found to have a very small TPA cross section, typically not more than few Göppert-Mayer units (GM, 1 GM 10 cm s photon molecule ) [10] and, thus, require unreasonable prolonged illumination with a tightly focused laser beam [10] , [11] . Our approach lies in special chemical modification of porphyrin, which enhances the molecule's TPA cross section without jeopardizing its ability to generate singlet oxygen. The design was based on structure-property relationships, known to enhance TPA cross section in organic -conjugated chromophores [12] [13] [14] . In particular, introduction of donors or acceptors of electronic density as substituent groups, extension of conjugation, and inclusion of donor--donor motifs within chromophore have all been previously utilized. In our particular case, this was achieved by an introduction of a 4-(diphenylaminostilbene)-substituent into the mesoposition of the tetrapyrrol ring. This results in a 20 times enhancement in TPA cross section at nm. In addition, the inclusion of the 2, 6-dichlorophenyl substituent assists intersystem crossing via an internal heavy atom effect.
II. EXPERIMENTAL SECTION
Structures of a typical new porphyrin DPASP [5-(4-diphenylaminostilbene), 15-(2, 6-dichlorophenyl)-21H, 23H-porphine] (I), as well as its nonsubstituted counterpart (II) and commercial tetraphenylporphyrin (III) are shown in Fig. 2 . The last two porphyrins were studied for purpose of comparison as model compounds. Compound I has been synthesized by condensing 10-(2, 6-dichlorophenyl) bilane with (4-diphenylaminostilbene) aldehyde under acidic conditions followed by oxidation with 2, 3-dichloro-5, 6-cyano-1, 4-benzoquinone. The way of synthesis of compound II is identical to that of I. Porphyrins I and II were purified by flash chromatography on silica using 20%-40% dichloromethane/hexane gradient and the structure of molecules was confirmed by spectroscopic analysis. Compound III was purchased from Aldrich and used as received.
Our laser system is schematically shown in Fig. 3 . It comprised a Ti : sapphire regenerative amplifier (CPA-1000, Clark MRX), which was operated at 1-kHz repetition rate and produced 150-fs pulses at 0.8 mJ energy per pulse. These pulses Fig. 3 . Schematic of experimental setup. For measurement of TPA spectra, a second harmonic of tunable OPA was used. For measurements of TPA cross sections and singlet oxygen two-photon photo generation, the output of regenerative amplifier was used directly (dashed arrow). For one-photon singlet oxygen photosensitization, the second harmonic of this radiation was used.
were parametrically down-converted in the optical parametric amplifier (OPA) (TOPAS, Quantronix), which yielded 100-fs pulses in the range from 1.1 to 1.8 m. TPA spectra were obtained by tuning the OPA with subsequent second-harmonic generation and registration of the porphyrin fluorescence. Absolute TPA cross sections were measured by comparing fluorescence intensity under OPE and TPE (see [15] for details). For sech temporal profile of excitation pulses and under the assumption that fluorescence quantum efficiency is the same for both modes of excitation, the two-photon cross section writes as follows: (1) Here, indexes 1 and 2 refer to the values measured under OPE and TPE, respectively, is the fluorescence signal recorded during time , is the molecule concentration (in molecule cm ), is the sample thickness (in cm), is the pulse duration (full width at half maximum in s), is the pulse repetition rate under TPE, is the average intensity (in W/cm ), is laser frequency (in hertz), and is the optical density of the sample at one-photon illumination wavelength.
In our experiments, we employed the fundamental of Ti-sapphire regenerative amplifier for TPE and its second harmonic for corresponding OPE. In both cases, the beam was slightly focused with a mm lens (L) into the 1-cm cell with sample solution through a pinhole (P) placed in front of the lens. Fluorescence was collected and focused on the entrance slit of a Jobin-Yvon monochromator with a spherical mirror. Special care were taken to geometrically eliminate the possible reabsorption effects.
In experiments with singlet oxygen generation, OPE was carried out at nm with average intensity of 0.5 W/cm and TPE was carried out at nm with average intensity of 15 W/cm . The laser beam was slightly focused to give a cylindrical irradiated volume of 1.5-mm diameter in both cases. The singlet oxygen luminescence spectrum was measured with a nitrogen-cooled Ge detector coupled with monochromator and lockin amplifier.
III. RESULTS AND DISCUSSION
TPA spectra of the three molecules are shown in Fig. 4 . Black solid lines represent the appropriately scaled one-photon absorption. All three molecules reveal a characteristic strong Soret band near 415 nm, accompanied by four relatively weak bands in the visible (not shown).
We observe that the TPA band does not coincide with any of the bands in the linear absorption spectrum. Quantum-mechanical calculations [16] , [17] show that key spectroscopic properties of porphyrins such as position and symmetry of main electronic energy levels are determined by the tetrapyrrol macrocycle and predict that the lowest excited state of symmetry should be positioned near the Soret band. According to selection rules, centrosymmetric molecules should have allowed onephoton transitions between the states of opposite parity and twophoton transitions between the states of same parity. Since the porphin ground state has symmetry, we assume that the observed TPA bands correspond to the transitions between the two states of parity.
The key point, however, is that DPASP (I) shows a very large (for porphyrins) TPA cross section with a measured maximum value of 80 10 GM at about 390 nm ( nm). The most significant fact is that this excitation wavelength falls well into the tissue transparency window, which makes the new approach very promising for future applications of PDT. Fig. 5 demonstrates that we were able to directly detect the production of singlet oxygen upon TPA of DPASP (I). Fig. 5(a) shows two luminescence spectra obtained upon either one-photon (dash) or two-photon (solid) excitation of DPASP, both normalized to unity. Note that the two spectra coincide well within experimental error and show both a characteristic peak near 1276 nm, which undoubtedly corresponds to the singlet oxygen luminescence spectrum [18] . Fig. 5(b) shows that the intensity of luminescence upon TPE increases as a square of the illumination intensity, which proves that the porphyrin is indeed excited by absorbing two near-IR photons simultaneously. Furthermore, if the solution was treated with a nitrogen sparge, the intensity of luminescence decreased because of the decreased oxygen concentration. Note that only with DPASP (I) could we reliably detect oxygen luminescence upon TPA. In the case of II and III, while a strong luminescence could be obtained upon OPE, with infrared excitation the signal was below the noise level of our detector.
IV. CONCLUSION
We have demonstrated, for the first time to the best of our knowledge, that singlet oxygen can be produced efficiently upon TPE of porphyrin photosensitizer with near-IR illumination within the tissue transparency window. This is achieved by chemically attaching special moieties to the porphyrin molecule, which are increasing the TPA cross section in near-IR. We believe that our results open new possibilities for designing tumor-specific drugs with a large TPA cross section, which may eventually lead to PDT-based treatment of various deep tumors.
